MARÍA ISABEL
FABREGAT ROMERO
Profesora titular de universidad
![Foto de MARÍA ISABEL](/img/nophoto.png)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (6)
2024
-
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche
Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495
2023
-
The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression
Hepatology, Vol. 78, Núm. 2, pp. 416-433
2021
-
Epithelial–mesenchymal transition (Emt) induced by tgf-β in hepatocellular carcinoma cells reprograms lipid metabolism
International Journal of Molecular Sciences, Vol. 22, Núm. 11
2017
-
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism
Scientific Reports, Vol. 7, Núm. 1
2016
-
Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis
Hepatology, Vol. 63, Núm. 2, pp. 604-619
2012
-
Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes
Journal of Biological Chemistry, Vol. 287, Núm. 19, pp. 15263-15274